Inside Precision Medicine September 12, 2024
CEO and founder Adityo Prakash explains the limits of current AI-based drug discovery and how new tech can unlock seemingly infinite chemical space
Adityo Prakash was pursuing a PhD in mathematical physics to become an academic in the early 1990s, but his dream was dashed when the Cold War ended. Suddenly, funding for esoteric fields like mathematical physics dried up, and many people preparing to be the next generation of academic physicists and mathematicians went into exile, looking for new opportunities.
“The people I knew that should have stayed and become the replacements for the very best researchers out there were all leaving going to Wall Street doing quantitative modeling and building weapons of mass destruction that have created in...
Today's Sponsors
Today's Sponsor